Stay updated on Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:02:38.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and a funding-status notice was removed; these are minor site maintenance updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:39:56.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding status notice was added. The site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:34:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:25:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.3.3 to v3.3.4; no study content, eligibility criteria, or navigation elements appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:05:35.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section includes Massachusetts as a location, replacing the previous Massachusetts Locations heading; the page version is updated to v3.3.3 and the HHS Vulnerability Disclosure link in the footer was removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:40:42.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabozantinib in Metastatic TNBC Clinical Trial page.